Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.

Methylation and hydroxymethylation of cytosine moieties in CpG islands of specific genes are epigenetic processes shown to be involved in the development of cervical (pre)neoplastic lesions. We studied global (hydroxy)methylation during the subsequent steps in the carcinogenic process of the uterine...

Full description

Bibliographic Details
Main Authors: Jobran M Moshi, Monique Ummelen, Frank Smedts, Frans C S Ramaekers, Anton H N Hopman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297008&type=printable
_version_ 1797194901149974528
author Jobran M Moshi
Monique Ummelen
Frank Smedts
Frans C S Ramaekers
Anton H N Hopman
author_facet Jobran M Moshi
Monique Ummelen
Frank Smedts
Frans C S Ramaekers
Anton H N Hopman
author_sort Jobran M Moshi
collection DOAJ
description Methylation and hydroxymethylation of cytosine moieties in CpG islands of specific genes are epigenetic processes shown to be involved in the development of cervical (pre)neoplastic lesions. We studied global (hydroxy)methylation during the subsequent steps in the carcinogenic process of the uterine cervix by using immunohistochemical protocols for the detection of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in paraffin-embedded tissues of the normal epithelia and (pre)malignant lesions. This approach allowed obtaining spatially resolved information of (epi)genetic alterations for individual cell populations in morphologically heterogeneous tissue samples. The normal ectocervical squamous epithelium showed a high degree of heterogeneity for both modifications, with a major positivity for 5-mC in the basal and parabasal layers in the ectocervical region, while 5-hmC immunostaining was even more restricted to the cells in the basal layer. Immature squamous metaplasia, characterized by expression of SOX17, surprisingly showed a decrease of 5-hmC in the basal compartments and an increase in the more superficial layers of the epithelium. The normal endocervical glandular epithelium showed a strong immunostaining reactivity for both modifications. At the squamocolumnar junctions, a specific 5-hmC pattern was observed in the squamous epithelium, resembling that of metaplasia, with the typical weak to negative reaction for 5-hmC in the basal cell compartment. The reserve cells underlying the glandular epithelium were also largely negative for 5-hmC but showed immunostaining for 5-mC. While the overall methylation status remained relatively constant, about 20% of the high-grade squamous lesions showed a very low immunostaining reactivity for 5-hmC. The (pre)malignant glandular lesions, including adenocarcinoma in situ (AIS) and adenocarcinoma showed a progressive decrease of hydroxymethylation with advancement of the lesion, resulting in cases with regions that were negative for 5-hmC immunostaining. These data indicate that inhibition of demethylation, which normally follows cytosine hydroxymethylation, is an important epigenetic switch in the development of cervical cancer.
first_indexed 2024-04-24T06:03:38Z
format Article
id doaj.art-e0f64a838b884ead8dc65e263fb9329a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-24T06:03:38Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e0f64a838b884ead8dc65e263fb9329a2024-04-23T05:31:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01194e029700810.1371/journal.pone.0297008Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.Jobran M MoshiMonique UmmelenFrank SmedtsFrans C S RamaekersAnton H N HopmanMethylation and hydroxymethylation of cytosine moieties in CpG islands of specific genes are epigenetic processes shown to be involved in the development of cervical (pre)neoplastic lesions. We studied global (hydroxy)methylation during the subsequent steps in the carcinogenic process of the uterine cervix by using immunohistochemical protocols for the detection of 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC) in paraffin-embedded tissues of the normal epithelia and (pre)malignant lesions. This approach allowed obtaining spatially resolved information of (epi)genetic alterations for individual cell populations in morphologically heterogeneous tissue samples. The normal ectocervical squamous epithelium showed a high degree of heterogeneity for both modifications, with a major positivity for 5-mC in the basal and parabasal layers in the ectocervical region, while 5-hmC immunostaining was even more restricted to the cells in the basal layer. Immature squamous metaplasia, characterized by expression of SOX17, surprisingly showed a decrease of 5-hmC in the basal compartments and an increase in the more superficial layers of the epithelium. The normal endocervical glandular epithelium showed a strong immunostaining reactivity for both modifications. At the squamocolumnar junctions, a specific 5-hmC pattern was observed in the squamous epithelium, resembling that of metaplasia, with the typical weak to negative reaction for 5-hmC in the basal cell compartment. The reserve cells underlying the glandular epithelium were also largely negative for 5-hmC but showed immunostaining for 5-mC. While the overall methylation status remained relatively constant, about 20% of the high-grade squamous lesions showed a very low immunostaining reactivity for 5-hmC. The (pre)malignant glandular lesions, including adenocarcinoma in situ (AIS) and adenocarcinoma showed a progressive decrease of hydroxymethylation with advancement of the lesion, resulting in cases with regions that were negative for 5-hmC immunostaining. These data indicate that inhibition of demethylation, which normally follows cytosine hydroxymethylation, is an important epigenetic switch in the development of cervical cancer.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297008&type=printable
spellingShingle Jobran M Moshi
Monique Ummelen
Frank Smedts
Frans C S Ramaekers
Anton H N Hopman
Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
PLoS ONE
title Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
title_full Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
title_fullStr Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
title_full_unstemmed Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
title_short Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
title_sort inhibition of cytosine 5 hydroxymethylation during progression of cancer precursor lesions in the uterine cervix
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297008&type=printable
work_keys_str_mv AT jobranmmoshi inhibitionofcytosine5hydroxymethylationduringprogressionofcancerprecursorlesionsintheuterinecervix
AT moniqueummelen inhibitionofcytosine5hydroxymethylationduringprogressionofcancerprecursorlesionsintheuterinecervix
AT franksmedts inhibitionofcytosine5hydroxymethylationduringprogressionofcancerprecursorlesionsintheuterinecervix
AT franscsramaekers inhibitionofcytosine5hydroxymethylationduringprogressionofcancerprecursorlesionsintheuterinecervix
AT antonhnhopman inhibitionofcytosine5hydroxymethylationduringprogressionofcancerprecursorlesionsintheuterinecervix